cardiovascular

  1. What's next for the UK?

    BMS UK recently announced that it would not longer be promoting Zeposia and Sotyktu. That means Innovative Medicines no longer exists as a BU, and they laid off ~30% of the UK staff. Of course the LT has taken care of their own as usual while other colleagues are pushed out. Oncology and...
    • Reepicheep
    • Thread
    • bms cardiovascular dermatology layoff oncology
    • Replies: 0
    • Forum: Bristol-Myers Squibb

  2. Cardio positions

    Looks like there are some Cardiovascular Sales Leader positions popping up on Job boards. Anyone have any insight on these?

  3. Amarin will bounce back

    I expect that Amarin will bounce back from the recent sell-off. Most of the doctors who participated in the AHA event has said that they will prescribe Vascepa and next year the biggies like Pfizer might considering acquiring Amarin...
    • anonymous
    • Thread
    • amarin biotech cardiovascular fda pfizer pharma sanofi statin trial vascepa
    • Replies: 9
    • Forum: Amarin

  4. Will Pfizer buy Amarin?

    There are rumors that Pfizer would take over Amarin, which skyrocketed today in the stock market as the cardiovascular study met primary and secondary endpoints using Vascepa drug. But Amarin has said that it's just a speculation...
    • anonymous
    • Thread
    • amarin astrazeneca biotech cardiovascular lipitor pfizer pharma reduce-it statin vascepa
    • Replies: 5
    • Forum: Pfizer
Top Bottom
Back